Prolight Diagnostics AB (publ) (NGM: PRLD)

Market Cap	90.57M
Revenue (ttm)	28.98M
Net Income (ttm)	-139.04M
Shares Out	702.09M
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,120,209
Open	n/a
Previous Close	0.135
Day's Range	n/a
52-Week Range	0.117 - 0.370
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 16
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2023, Prolight Diagnostics AB's revenue was 24.22 million, a decrease of -31.35% compared to the previous year's 35.27 million. Losses were -135.46 million, 1003.5% more than in 2022.